Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 3/20 | 0.40 |
| ▸ | ICMT | O60725 | 5/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.37 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.37 |
| ▸ | RXRB | P28702 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13506806 | 0.87 | L3MBTL1 (0.37) | MAPK14MAOBMAOARXRARXRB | |
| SCHEMBL13507562 | 0.85 | MAOB (0.51) | MAOBMAOARXRARXRB | |
| SCHEMBL13507038 | 0.85 | RXRA (0.39) | ICMTMAOBMAOALMNARXRA | |
| SCHEMBL13507919 | 0.84 | LIMK1 (0.46) | MAPK14MAOBNR3C1MAOA | |
| SCHEMBL24994009 | 0.82 | RXRA (0.54) | MAOBLMNARXRARXRB | |
| SCHEMBL14425470 | 0.81 | ICMT (0.47) | ICMTNR3C1MAP4K4SIRT2 | |
| SCHEMBL13564062 | 0.80 | MAOB (0.47) | MAPK14ICMTMAOBNR3C1MAOA | |
| SCHEMBL13506860 | 0.78 | RXRA (0.47) | MAOBLMNARXRARXRB | |
| SCHEMBL13506945 | 0.77 | HTR1D (0.43) | MAOBRXRARXRB | |
| SCHEMBL13507152 | 0.77 | RXRA (0.43) | MAOBLMNARXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100032658-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
| US-20100032658-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100032658-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | MAPK14 3401/4885ICMT 235/4885MAOB 446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.